Fei Qu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Inflammasome and immune disorders 2
-
- Immune Cell Function and Interaction 3
- Immune cells in cancer 2
- Co-authors
- Kun Zhang (3 shared papers)Pan Wang (3 shared papers)Quanhong Liu (3 shared papers)Yixiang Li (2 shared papers)Yin Shi (2 shared papers)Chengren Li (1 shared paper)Xiaobing Wang (1 shared paper)Yurong Tan (6 shared papers)
- Journals
- Cell Biology International (3 papers)Journal of Ethnopharmacology (2 papers)Nano Research (2 papers)International Immunopharmacology (1 paper)Chemico-Biological Interactions (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Qu
24 papers receiving 530 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 80
- Biomaterials 53
- Biomedical Engineering 150
- Pulmonary and Respiratory Medicine 82
- Molecular Biology 184
Countries citing papers authored by Fei Qu
This map shows the geographic impact of Fei Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Qu more than expected).
Fields of papers citing papers by Fei Qu
This network shows the impact of papers produced by Fei Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Qu. The network helps show where Fei Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 166 | |
| 2 | 2017 | 49 | |
| 3 | 2018 | 46 | |
| 4 | 2022 | 38 | |
| 5 | 2006 | 34 | |
| 6 | 2008 | 34 | |
| 7 | 2018 | 21 | |
| 8 | 2019 | 18 | |
| 9 | 2007 | 17 | |
| 10 | 2017 | 17 | |
| 11 | 2023 | 14 | |
| 12 | 2007 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 2010 | 10 | |
| 15 | 2024 | 10 | |
| 16 | 2023 | 10 | |
| 17 | 2010 | 5 | |
| 18 | 2022 | 5 | |
| 19 | The role of bronchial epithelial cells in airway hyperresponsiveness. | 2007 | 5 |
| 20 | 2025 | 4 |
About Fei Qu
Fei Qu is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Physiology and Cancer Research, having authored 26 papers that have together received 530 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (3 papers), Immune cells in cancer (2 papers), Cystic Fibrosis Research Advances (2 papers), Inflammasome and immune disorders (2 papers), MicroRNA in disease regulation (2 papers), Asthma and respiratory diseases (2 papers), Neonatal Respiratory Health Research (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (80 citations), Biomaterials (53 citations), Biomedical Engineering (150 citations), Pulmonary and Respiratory Medicine (82 citations) and Molecular Biology (184 citations). Fei Qu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Kun Zhang, Pan Wang, Quanhong Liu, Yixiang Li, Yin Shi, Chengren Li, Xiaobing Wang, Yurong Tan, Xiaoqun Qin and Yang Xiang. Their work appears in journals such as Cell Biology International, Journal of Ethnopharmacology, Nano Research, International Immunopharmacology and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.